Dr: New MS drug a ‘big step in the right direction’
02:35
Dr. Robert Fox, a neurologist at the Cleveland Clinic who headed the BG-12 study, says the drug is not a cure for MS, but it is well tolerated and helps decrease new lesions. Sept. 20, 2012
UP NEXT
Community shaken after student killed in shooting at Texas high school
01:44
U.S. aid worker and French journalist freed after being held hostage for years
01:24
Immediate action needed to address global warming, according to new U.N. report
02:27
Meet the Press NOW — March 20
49:49
New report proves disparities in PTSD care for Black veterans
05:22
War crimes warrant for Putin could push Russia, China together